questionText: To ask the Secretary of State for Health and Social Care, when the drug Daraxonrasib will be available to pancreatic cancer patients on the NHS.
answerText: Daraxonrasib is not currently licensed in the United Kingdom. Should the manufacturer submit an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a product licence, the MHRA has processes in place to review and assess its b...
heading: Pancreatic Cancer: Daraxonrasib